Effect of recombinant human erythropoietin on quality of life in cancer patients receiving chemotherapy: results of a randomized, controlled trial. (Q53385753)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Effect of recombinant human erythropoietin on quality of life in cancer patients receiving chemotherapy: results of a randomized, controlled trial.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12782431%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Effect of recombinant human erythropoietin on quality of life in cancer patients receiving chemotherapy: results of a randomized, controlled trial (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12782431%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

quality of life

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Gregoris Iconomou

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12782431%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12782431%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Angelos Koutras

2

object named as

Angelos Koutras

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12782431%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Apostolos G Vagenakis

4

object named as

Apostolos G Vagenakis

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12782431%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

Antonis Rigopoulos

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12782431%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 June 2003

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12782431%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Journal of Pain and Symptom Management

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12782431%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

25

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12782431%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12782431%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

512-518

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12782431%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Effect of subcutaneous recombinant human erythropoietin in cancer patients receiving radiotherapy: final report of a randomized, open-labelled, phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2803%2900070-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Epoetin alfa therapy increases hemoglobin levels and improves quality of life in patients with cancer-related anemia who are not receiving chemotherapy and patients with anemia who are receiving chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2803%2900070-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy-induced anemia in adults: incidence and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2803%2900070-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Anaemia and its functional consequences in cancer patients: current challenges in management and prospects for improving therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2803%2900070-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Symptomatology of anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2803%2900070-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The use of epoetin alfa to increase and maintain hemoglobin levels during radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2803%2900070-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The impact of hemoglobin levels on treatment outcomes in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2803%2900070-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Oxygen status of malignant tumors: pathogenesis of hypoxia and significance for tumor therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2803%2900070-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Anemia and fatigue in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2803%2900070-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2803%2900070-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2803%2900070-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2803%2900070-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Epoetin treatment of anemia associated with cancer therapy: a systematic review and meta-analysis of controlled clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2803%2900070-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2803%2900070-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2803%2900070-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized phase III trial evaluating the role of erythropoietin in the prevention of chemotherapy-induced anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2803%2900070-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Erythropoietin treatment under polychemotherapy in patients with gynecologic malignancies: a prospective, randomized, double-blind placebo-controlled multicenter study.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2803%2900070-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant human erythropoietin for the treatment of anemia in children with solid malignant tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2803%2900070-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Epoetin alpha prevents anaemia and reduces transfusion requirements in patients undergoing primarily platinum-based chemotherapy for small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2803%2900070-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Multiple significance tests: the Bonferroni method

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2803%2900070-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Health-related quality of life in patients treated with temozolomide versus procarbazine for recurrent glioblastoma multiforme.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2803%2900070-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0885-3924(03)00070-8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12782431%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

release_w5gxyesdpbhojcc5o2u46zjfim

1 reference

https://api.fatcat.wiki/v0/release/w5gxyesdpbhojcc5o2u46zjfim

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12782431%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53385753&oldid=2051699276"